Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Recruiting 25Active not recruiting 14Completed 9Terminated 4Suspended 4Withdrawn 2Unknown 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 6Melanoma 6Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Neoplasms 3Head and Neck Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 2Skin Neoplasms 2Sarcoma, Kaposi 2Sarcoma 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Inflammatory Breast Neoplasms 2HIV Infections 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Unspecified Adult Solid Tumor, Protocol Specific 1Turcot syndrome 1Thrombocytosis 1

Interventions

pembrolizumab 30Capecitabine 24Bevacizumab 23Cyclophosphamide 22Gemcitabine 21Paclitaxel 20Nivolumab 19Fluorouracil 19Docetaxel 18aldesleukin 17Leucovorin 17Irinotecan 17Oxaliplatin 15Interleukin-2 14Radiosurgery 13Cisplatin 13Cetuximab 13fludarabine 12Carboplatin 12Albumin-Bound Paclitaxel 11fludarabine phosphate 10Ipilimumab 10Drug Therapy 10Doxorubicin 10Sunitinib 9Radiotherapy 9Everolimus 9130-nm albumin-bound paclitaxel 9Trastuzumab 8Temozolomide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Neoplasm Metastasis × Biopsy × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
36 enrolled 7 charts
Breast

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01336985 2019-12-17

Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
5 enrolled
DermatologicGastrointestinal

Liver Neoplasms, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT01855061 2018-03-09

CPCT-01

UMC Utrecht

Terminated
79 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡